Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Olema Pharmaceuticals, Inc.’s reported figures.
The source filing: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 7:10 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-218156
FAQ
- What is Olema Pharmaceuticals, Inc.'s EBIT?
- Olema Pharmaceuticals, Inc. (OLMA) reported EBIT of -$57.99M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s EBIT changed year-over-year?
- Olema Pharmaceuticals, Inc.'s EBIT decreased by 66.3% year-over-year, from -$34.87M to -$57.99M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s EBIT has grown at a 25.7% compound annual growth rate (CAGR), from -$71.49M to -$178.7M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Olema Pharmaceuticals, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude